Keeley-Teton Advisors’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.29M Buy
69,928
+12,929
+23% +$233K 0.16% 194
2024
Q4
$939K Sell
56,999
-27,726
-33% -$393K 0.11% 232
2024
Q3
$1.19M Hold
84,725
0.13% 216
2024
Q2
$613K Hold
84,725
0.08% 257
2024
Q1
$684K Hold
84,725
0.08% 251
2023
Q4
$579K Buy
84,725
+48,725
+135% +$271K 0.07% 262
2023
Q3
$180K Buy
+36,000
New +$249K 0.03% 340

Other funds holding AXGN

Keeley-Teton Advisors's AXGN Position: Q1 2025 in Review

Keeley-Teton Advisors increased its Axogen (AXGN) stake by 23% in Q1 2025, buying an estimated $233K and bringing the position to 69,928 shares worth $1.29M. The position accounts for 0.16% of the portfolio, ranked #194.

Keeley-Teton Advisors first reported a position in AXGN in Q3 2023 and has held it in 7 quarters since. 181 funds tracked by Wall St. Rank hold AXGN as of Q1 2025.

  • Keeley-Teton Advisors held 69,928 shares of Axogen worth $1.29M as of Q1 2025.
  • Keeley-Teton Advisors bought 12,929 Axogen shares in Q1 2025, an estimated $233K.
  • Axogen made up 0.16% of Keeley-Teton Advisors's portfolio in Q1 2025, its #194 holding.
  • Keeley-Teton Advisors first reported a position in Axogen in Q3 2023 and has held it in 7 quarters since.
  • 181 funds tracked by Wall St. Rank held Axogen as of Q1 2025.

Based on Keeley-Teton Advisors's 13F filing for Q1 2025, filed 14 May 2025.